125 related articles for article (PubMed ID: 3923141)
21. Effect of standard heparin and a low molecular weight heparin on thrombolytic and fibrinolytic activity of single-chain urokinase plasminogen activator in vitro.
Lourenço DM; Dosne AM; Kher A; Samama M
Thromb Haemost; 1989 Nov; 62(3):923-6. PubMed ID: 2556812
[TBL] [Abstract][Full Text] [Related]
22. Human articular cartilage contains an inhibitor of plasminogen activator.
Yamada H; Stephens RW; Nakagawa T; McNicol D
J Rheumatol; 1988 Jul; 15(7):1138-43. PubMed ID: 3139880
[TBL] [Abstract][Full Text] [Related]
23. Effects of castration on plasminogen activator activities and plasminogen activator inhibitor type 1 in the rat ventral prostate.
Wilson MJ; Ludowese C; Sinha AA; Estensen RD
Prostate; 1996 Apr; 28(4):239-50. PubMed ID: 8602400
[TBL] [Abstract][Full Text] [Related]
24. Purification and characterization of single-chain urokinase-type plasminogen activator (pro-urokinase) from human A431 cells.
Corti A; Nolli ML; Soffientini A; Cassani G
Thromb Haemost; 1986 Oct; 56(2):219-24. PubMed ID: 3101222
[TBL] [Abstract][Full Text] [Related]
25. Isolation of a proteinase with plasminogen-activating activity from Lachesis muta muta (bushmaster) snake venom.
Sanchez EF; Santos CI; Magalhaes A; Diniz CR; Figueiredo S; Gilroy J; Richardson M
Arch Biochem Biophys; 2000 Jun; 378(1):131-41. PubMed ID: 10871053
[TBL] [Abstract][Full Text] [Related]
26. [New thrombolytic agents in myocardial infarction].
Charbonnier B; Lang M; Brochier M
Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222
[TBL] [Abstract][Full Text] [Related]
27. Purification and characterization of single-chain urokinase-type plasminogen activator from human cell cultures.
Stump DC; Lijnen HR; Collen D
J Biol Chem; 1986 Jan; 261(3):1274-8. PubMed ID: 3080423
[TBL] [Abstract][Full Text] [Related]
28. Potentiation by Lys-plasminogen of clot lysis by single or two chain urokinase-type plasminogen activator or tissue-type plasminogen activator.
Watahiki Y; Scully MF; Ellis V; Kakkar VV
Thromb Haemost; 1989 Jun; 61(3):502-6. PubMed ID: 2508259
[TBL] [Abstract][Full Text] [Related]
29. Kinetics of the reaction between urokinase and an inhibitor of fibrinolysis from placental tissue.
Christensen U; Holmberg L; Bladh B; Astedt B
Thromb Haemost; 1982 Aug; 48(1):24-6. PubMed ID: 6813991
[TBL] [Abstract][Full Text] [Related]
30. Rapid isolation of high molecular weight urokinase from native human urine.
Huber K; Kirchheimer J; Binder BR
Thromb Haemost; 1982 Jun; 47(3):197-202. PubMed ID: 7051408
[TBL] [Abstract][Full Text] [Related]
31. The fast-acting inhibitor of tissue-type plasminogen activator in plasma is also the primary plasma inhibitor of urokinase.
Kruithof EK; Tran-Thang C; Bachmann F
Thromb Haemost; 1986 Feb; 55(1):65-9. PubMed ID: 3085266
[TBL] [Abstract][Full Text] [Related]
32. Different inhibition of one and two chain tissue plasminogen activator by a placental inhibitor studied with two tripeptide-p-nitroanilide substrates.
Astedt B; Bladh B; Christensen U; Lecander I
Scand J Clin Lab Invest; 1985 Sep; 45(5):429-35. PubMed ID: 2930896
[TBL] [Abstract][Full Text] [Related]
33. Plasma fibrinolysis after intraduodenal administration of urokinase in rats.
Sumi H; Seiki M; Morimoto N; Tsushima H; Maruyama M; Mihara H
Enzyme; 1985; 33(3):122-7. PubMed ID: 4054071
[TBL] [Abstract][Full Text] [Related]
34. Expression and localization of the urokinase-type plasminogen activator receptor (uPAR) in the human placenta.
Nishida Y; Hayashi Y; Imai Y; Itoh H
Kobe J Med Sci; 1998 Feb; 44(1):31-43. PubMed ID: 9846056
[TBL] [Abstract][Full Text] [Related]
35. Detection and partial characterization of a specific plasminogen activator inhibitor in human chondrocyte cultures.
Yamada H; Stephens RW; Nakagawa T; McNicol D
J Biochem; 1988 Dec; 104(6):960-7. PubMed ID: 3149640
[TBL] [Abstract][Full Text] [Related]
36. [Isolation and purification of placental coagulation inhibitor].
Shidara Y
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Dec; 36(12):2583-92. PubMed ID: 6520478
[TBL] [Abstract][Full Text] [Related]
37. Purification and characterization of a plasminogen activator secreted by a pig kidney cell line.
Sudol M; Reich E
Biochem J; 1984 May; 219(3):971-8. PubMed ID: 6430276
[TBL] [Abstract][Full Text] [Related]
38. Partial purification and characterization of keratokinase, the fibrinolytic activator of the cornea.
Pandolfi M; Lantz E
Exp Eye Res; 1979 Nov; 29(5):563-71. PubMed ID: 393529
[No Abstract] [Full Text] [Related]
39. Isolation and characterization of a urokinase-type plasminogen activator (Mr = 54,000) from cultured human endothelial cells indistinguishable from urinary urokinase.
Booyse FM; Osikowicz G; Feder S; Scheinbuks J
J Biol Chem; 1984 Jun; 259(11):7198-205. PubMed ID: 6539333
[TBL] [Abstract][Full Text] [Related]
40. Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture.
Rijken DC; Collen D
J Biol Chem; 1981 Jul; 256(13):7035-41. PubMed ID: 6787058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
